Alterity Therapeutics Limited logo

Alterity Therapeutics Limited

ASX:ATH.AX

Overview | Financials
Company Name Alterity Therapeutics Limited
Symbol ATH.AX
Currency AUD
Price 0.004
Market Cap 21,281,360
Dividend Yield 0%
52-week-range 0.002 - 0.009
Industry Biotechnology
Sector Healthcare
CEO Mr. Geoffrey Paul Kempler B.Sc, B.Sc.
Website https://alteritytherapeutics.com

An error occurred while fetching data.

About Alterity Therapeutics Limited

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing

Related Stocks

IDT Australia Limited logo

IDT Australia Limited

IDT.AX

0.127 AUD

Neurotech International Limited logo

Neurotech International Limited

NTI.AX

0.052 AUD

Althea Group Holdings Limited logo

Althea Group Holdings Limited

AGH.AX

0.04 AUD

Resonance Health Limited logo

Resonance Health Limited

RHT.AX

0.052 AUD

Lumos Diagnostics Holdings Limited logo

Lumos Diagnostics Holdings Limited

LDX.AX

0.034 AUD

Cryosite Limited logo

Cryosite Limited

CTE.AX

0.92 AUD

Imricor Medical Systems, Inc. logo

Imricor Medical Systems, Inc.

IMR.AX

0.69 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD